FDA Warns Drugmaker Aveva Over Plant Problems

Law360, New York (June 9, 2010, 6:36 PM EDT) -- The U.S. Food and Drug Administration has sent a warning letter to Nitto Denko Corp. unit Aveva Drug Delivery Systems Inc., scolding the pharmaceutical manufacturer for not making sufficient corrective actions to a Florida plant after an inspection uncovered a variety of safety deficiencies last year.

Aveva makes transdermal patches for a variety of drugs including nicotine, fentanyl, sancuso, granisetron and clonidine, which can be used to treat symptoms such as insomnia, attention-deficit hyperactivity disorder, pain, and nausea.

Between October and December 2009 the FDA inspected...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.